The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type B
Open accessAbstract
Seventy consecutive HBsAg– and HBeAg–positive patients with biopsy–proven chronic hepatitis were followed prospectively with serial determinations of SGPT levels and hepatitis B virus serum markers including HBsAg, HBeAg, anti–HBeand hepatitis B virus DNA. During a period of 1 to 11 years (mean ± S.D.: 5.0 ± 2.3 years), 28 patients remained persistently HBeAg positive, most with continuing biochemical and histologic activity, while 41 cases seroconverted to anti–HBe. One patient became HBeAg and anti–HBe negative. After seroconversion, 87.8% ofthe cases showed sustained normalization of SGPT, and clearance of hepatitis B virus DNA from serum and histologic improvement was documented in 79% of the cases who had a control liver biopsy, while 15.8% developed cirrhosis. In two patients (4.9%), the disease remained active despite seroconversion, and both cases had evidence of continuing hepatitis B virus replication. Finally, reactivation of liver damage and of hepatitis B virus replication was observed in three additional patients (7.3%) who had transiently normalized SGPT after seroconversion. All 70 patients were analyzed for hepatitis delta virus markers, and only two persistently HBeAg–positive cases were found positivefor antibody to hepatitis delta virus in serum, one also having hepatitis delta antigenin the liver. These findings indicate that, in chronic hepatitis type B, termination ofvirus replication is associated in most patients with biochemical and histologic regression of inflammatory activity. After anti–HBe seroconversion has occurred, virusreplication and liver disease may persist or reactivate in a small proportion of patients thus giving origin to the well–recognized group of anti–HBe positive, hepatitis B virus DNA–positive chronic hepatitis type B.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A CLASSIFICATION OF CHRONIC HEPATITIS
de Groote, J., Desmet, V. J., Gedigk, P., Korb, G., Popper, H., Poulsen, H. E., Scheuer, P. J., Schmid, M., Thaler, H., Uehlinger, E., et al. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90710-1 · Cited by 856
Okada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., & Mayumi, M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197604012941402 · Cited by 728
Chu, C.-M., Karayiannis, P., Fowler, M. J. F., Monjardino, J., Liaw, Y.-F., & Thomas, H. C. (1985) · Hepatology · doi:10.1002/hep.1840050315 · Cited by 419
Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy
Hoofnagle, J. H., Dusheiko, G. M., Schafer, D. F., Jones, E. A., Micetich, K. C., Young, R. C., & Costa, J. C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-4-447 · Cited by 396
Iversen, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90876-5 · Cited by 390
Liaw, Y.-F., Chu, C.-M., Su, I.-J., Huang, M.-J., Lin, D.-Y., & Chang-Chien, C.-S. (1983) · Gastroenterology · doi:10.1016/s0016-5085(83)80114-0 · Cited by 341
Stevens, C. E., Neurath, R. A., Beasley, R. P., & Szmuness, W. (1979) · Journal of Medical Virology · doi:10.1002/jmv.1890030310 · Cited by 331
Spontaneous reactivation of chronic hepatitis B virus infection
Davis, G. L., Hoofnagle, J. H., & Waggoner, J. G. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90406-2 · Cited by 288
OLEOANILIDES AND SPANISH OIL POISONING
Gordon, R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90621-8 · Cited by 207
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-1-146_2 · Cited by 176
Cited by
Lok, A. S. F., & McMahon, B. J. (2007) · Hepatology · doi:10.1002/hep.21513 · Cited by 3,087
Chronic hepatitis B: Update 2009 #
Lok, A. S. F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,831
Lee, W. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372406 · Cited by 2,569
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Dienstag, J. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801644 · Cited by 961
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
Lok, A. S. F., & McMahon, B. J. (2001) · Hepatology · doi:10.1053/jhep.2001.29401 · Cited by 709
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
Yu, M.-W., Yeh, S.-H., Chen, P.-J., Liaw, Y.-F., Lin, C.-L., Liu, C.-J., Shih, W.-L., Kao, J.-H., Chen, D.-S., & Chen, C.-J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji043 · Cited by 569
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
McMahon, B. J., Holck, P., Bulkow, L., & Snowball, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00006 · Cited by 431
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
De Jongh, F. E., Janssen, H. L. A., De Man, R. A., Hop, W. C. J., Schalm, S. W., & Van Blankenstein, M. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91188-a · Cited by 418
Keeffe, E. B., Dieterich, D. T., Han, S. B., Jacobson, I. M., Martin, P., Schiff, E. R., Tobias, H., & Wright, T. L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.016 · Cited by 374
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States
Keeffe, E. B., Dieterich, D. T., Han, S.-H. B., Jacobson, I. M., Martin, P., Schiff, E. R., Tobias, H., & Wright, T. L. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00312-4 · Cited by 359
Lok, A. S. F., Lai, C.-L., Wu, P.-C., Leung, E. K. Y., & Lam, T.-S. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90613-5 · Cited by 326
Realdi, G., The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP), Fattovich, G., Hadziyannis, S., Schalm, S. W., Almasio, P., Sanchez-Tapias, J., Christensen, E., Giustina, G., & Noventa, F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80115-0 · Cited by 301
Self-citationYu, M.-W., Hsu, F.-C., Sheen, I.-S., Chu, C.-M., Lin, D.-Y., Chen, C.-J., & Liaw, Y.-F. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009060 · Cited by 289
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
Gish, R. G., Given, B. D., Lai, C.-L., Locarnini, S. A., Lau, J. Y. N., Lewis, D. L., & Schluep, T. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.008 · Cited by 259
Keeffe, E. B., Zeuzem, S., Koff, R. S., Dieterich, D. T., Esteban–Mur, R., Gane, E. J., Jacobson, I. M., Lim, S. G., Naoumov, N., Marcellin, P., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.05.004 · Cited by 257
Ghozy, S., Nam, N. H., Radwan, I., Karimzadeh, S., Tieu, T. M., Hashan, M. R., Abbas, A. S., Eid, P. S., Vuong, N. L., Khang, N. V., et al. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2089 · Cited by 32
Metadata
- Authors
- Fattovich, G., Rugge, M., Brollo, L., Pontisso, P., Noventa, F., Guido, M., Alberti, A., & Realdi, G.
- Venue
- Hepatology
- Published
- 1986-03
- Volume
- 6
- Issue
- 2
- Pages
- 167-171
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2063885826
- Cited by
- 273
- References
- 10
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.